C3 Glomerulonephritis Presenting With Nephritic and Nephrotic Syndromes: Spontaneous Remission After Six Months on Dialysis

Francisco Gonçalves; Nídia Marques; Roberto Silva; Luis Mendonça; Bernardo Faria

doi:10.7759/cureus.50396

journal article Dec 12, 2023

C3 Glomerulonephritis Presenting With Nephritic and Nephrotic Syndromes: Spontaneous Remission After Six Months on Dialysis

Francisco Gonçalves Nídia Marques Roberto Silva Luis Mendonça Bernardo Faria

Cureus · Springer Science and Business Media LLC

View at Publisher Save 10.7759/cureus.50396

Topics

No keywords indexed for this article. Browse by subject →

References

10

[1]

Smith RJ, Appel GB, Blom AM, et al.. C3 glomerulopathy - understanding a rare complement-driven renal disease. Nat Rev Nephrol. 2019, 15:129-43. 10.1038/s41581-018-0107-2 10.1038/s41581-018-0107-2

[2]

Caravaca-Fontán F, Lucientes L, Cavero T, Praga M. Update on C3 glomerulopathy: a complement-mediated disease. Nephron. 2020, 144:272-80. 10.1159/000507254 10.1159/000507254

[3]

Hou J, Ren KY, Haas M. C3 glomerulopathy: a review with emphasis on ultrastructural features. Glomerular Dis. 2022, 2:107-20. 10.1159/000524552 10.1159/000524552

[4]

Moore I, Strain L, Pappworth I, et al.. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome. Blood. 2010, 115:379-87. 10.1182/blood-2009-05-221549 10.1182/blood-2009-05-221549

[5]

Gómez Delgado I, Sánchez-Corral P. Contribution of functional and quantitative genetic variants of complement factor H and factor H-related (FHR) proteins on renal pathology. Nefrologia (Engl Ed). 2022, 42:280-9. 10.1016/j.nefroe.2022.09.002 10.1016/j.nefroe.2022.09.002

[6]

Zipfel PF, Edey M, Heinen S, et al.. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome. PLoS Genet. 2007, 3:e41. 10.1371/journal.pgen.0030041 10.1371/journal.pgen.0030041

[7]

Blanc C, Togarsimalemath SK, Chauvet S, et al.. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases. J Immunol. 2015, 194:5129-38. 10.4049/jimmunol.1402770 10.4049/jimmunol.1402770

[8]

Tschernoster N, Erger F, Walsh PR, et al.. Unraveling structural rearrangements of the CFH gene cluster in atypical hemolytic uremic syndrome patients using molecular combing and long-fragment targeted sequencing. J Mol Diagn. 2022, 24:619-31. 10.1016/j.jmoldx.2022.02.006 10.1016/j.jmoldx.2022.02.006

[9]

Michels MA, Volokhina EB, van de Kar NC, van den Heuvel LP. Challenges in diagnostic testing of nephritic factors. Front Immunol. 2022, 13:1036136. 10.3389/fimmu.2022.1036136 10.3389/fimmu.2022.1036136

[10]

Caravaca-Fontán F, Rivero M, Cavero T, et al.. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy. Clin Kidney J. 2022, 15:1737-46. 10.1093/ckj/sfac108 10.1093/ckj/sfac108

Metrics

0

Citations

10

References

Details

Published: Dec 12, 2023

Authors

Cite This Article

Francisco Gonçalves, Nídia Marques, Roberto Silva, et al. (2023). C3 Glomerulonephritis Presenting With Nephritic and Nephrotic Syndromes: Spontaneous Remission After Six Months on Dialysis. Cureus. https://doi.org/10.7759/cureus.50396

C3 Glomerulonephritis Presenting With Nephritic and Nephrotic Syndromes: Spontaneous Remission After Six Months on Dialysis

You May Also Like